Malaria Radical Cure Drug Efficacy Clinical Study
Closed Special Notice Posted
- Agency
- Not on record
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Syracuse, New York 13210, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency Contracting Activity (DHACA), in conjunction with the Walter Reed Army Institute of Research (WRAIR) and the Armed Forces Research Institute of Medical Sciences (AFRIMS), has published a Notice of Intent to sole source a federal contract for malaria drug research. This Special Notice, posted on March 12, 2026, indicates the government's intention to award the contract to The Research Foundation for The State University of New York (SUNY) located in Syracuse, New York. The contract falls under NAICS Code 541715 (Research and Development in the Physical, Engineering, and Life Sciences) and PSC Code AN11 (Health R&D Services). This is a non-personal services research effort that does not utilize a competitive set-aside process.
The contract objective is to conduct two clinical studies evaluating the safety and efficacy of radical cure therapies for relapsing malaria caused by Plasmodium vivax, with a specific focus on the drug tafenoquine. The first study will assess safety and pharmacokinetics in healthy adults in the United States, while the second will measure efficacy in treating malaria in an endemic area in Thailand. Interested parties may submit meaningful capability statements by April 25, 2026 at 08:00 AM EDT to Ashley Atkins at ashley.n.atkins.civ@health.mil in PDF, MS Word, or Excel format only; phone calls are not accepted. If no meaningful submissions are received by this deadline, the solicitation will proceed as a sole source award to SUNY. The capability statement submission opportunity provides a pathway for qualified contractors to demonstrate their ability to perform this specialized medical research requirement before a sole source determination is finalized.
Notice text
See attached PDR document.
Files
| File | Type | Posted |
|---|---|---|
| B01. Notice of Intent to Sole Source - as of 03.12.2026.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Special Notice | |
| Malaria Radical Cure Drug Efficacy Clinical Study | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NOTICE OF INTENT TO SOLE SOURCE for the Development of a Handheld Device for Rapid Assessment of Burn Sepsis Risk | — | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity